Skip to main content
JS Link, Inc. logo

JS Link, Inc. — Investor Relations & Filings

Ticker · 127120 ISIN · KR7127120004 KO Manufacturing
Open in API
Filings indexed 601 across all filing types
Latest filing 2025-01-15 Capital/Financing Update
Country KR South Korea
Listing KO 127120

About JS Link, Inc.

https://en.jslink.co.kr/

JS Link, Inc. is a company with dual operations in biotechnology and advanced materials manufacturing. Formerly known as DNA Link, Inc., its biotechnology division is a genome-based research and development firm. It specializes in genomic mass analysis technology, providing sequencing and analysis services for DNA, RNA, and other genomic data to advance personalized medicine. The company also operates a division dedicated to the manufacturing of high-performance sintered permanent magnets, which are produced using rare earth materials.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시) (제13회차 CB)
Capital/Financing Update Classification · 1% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a convertible bond, or CB). It details the issuance amount, payment date, and the nature of the security. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2025-01-15 Korean
최대주주변경을수반하는주식양수도계약체결
Major Shareholding Notification Classification · 1% confidence The document is a formal regulatory announcement regarding a 'Change in Largest Shareholder' due to a stock purchase agreement. This type of filing is a standard corporate disclosure in South Korean markets (DART system) concerning changes in control and major shareholding structure. While it involves share transfers, it is specifically categorized as a major corporate event announcement rather than a simple director's dealing or a general regulatory filing, fitting best under 'Major Shareholding Notification' (MRQ) as it details the change in the largest shareholder status.
2025-01-07 Korean
거래처와의거래중단
Legal Proceedings Report Classification · 1% confidence The document is a regulatory disclosure from a Korean company (DNAlink) regarding the suspension of business with a government agency (Public Procurement Service) due to a sanction. This type of disclosure, which details legal/regulatory actions and their impact on business operations, falls under the category of general regulatory announcements or legal proceedings. Given the specific nature of the disclosure regarding a regulatory sanction and its impact, 'RNS' (Regulatory Filings) is the most appropriate classification as it serves as the fallback for miscellaneous regulatory disclosures.
2025-01-06 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) from DNA Link, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). This document outlines the issuance of new shares, the purpose of the capital raise (operational and facility funds), the third-party allocation details, and the pricing methodology. In the context of Korean corporate filings (DART system), this is a regulatory disclosure regarding capital structure changes, which falls under the 'Share Issue/Capital Change' category.
2025-01-06 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and a subsequent amendment (정정신고) to that report. It details the terms of the convertible bonds, including conversion price adjustments, interest rates, and maturity dates. This type of filing is a standard regulatory disclosure for capital structure changes and financing activities in the Korean market, which falls under the 'Capital/Financing Update' category.
2024-12-27 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a correction to a previously filed 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It details specific amendments to the terms of the convertible bonds, such as the removal of certain conversion price adjustment clauses. This is a regulatory filing submitted to the Financial Supervisory Service and the Korea Exchange, which falls under the category of capital and financing updates.
2024-12-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.